In this study, we show that from all the overexpressed KLKs in colon cancer-derived cell lines, KLK6 was found to be among the major highly expressed kallikrein-related peptidases in vitro and capable to control cell proliferation through PAR2 signaling. Here, KLK6 is linked to malignant colon neoplasm.